Deepening Cooperation on Medical Goods and Services Trade
54. The hub concept draws inspiration from a 2007 WHO program to provide seed grants to manufacturers in LMICs to establish or improve pandemic influenza vaccine production capacity (Hendriks et al. 2011). The companies involved were supported by an influenza vaccine technology platform (“hub”) at the Netherlands Vaccine Institute for training and technology transfer. During its first two years of operation, a robust and transferable monovalent pilot process for egg-based inactivated whole virus influenza A vaccine production was established under international GMP standards as well as in-process and release assays. The hub developed training tools, including a practical handbook on production and quality control, and provided hands-on training courses to employees from manufacturers in LMICs. 55. A possible model is provided by Accumulus Synergy, a nonprofit company providing a cloudbased platform to support interactions between the biopharmaceutical industry and health authorities worldwide, leveraging advanced technology and tools for data exchange to support global regulatory reliance mechanisms by giving all agencies access to information and data provided by vaccine manufacturers, run regulatory work-sharing activities, provide parallel review of dossiers, and produce reliance- or recognition-based assessments, under a single and global management system. For more information, see https://www.accumulus.org/. 56. “The COVAX Marketplace,” Coalition for Epidemic Preparedness Innovations (CEPI) website: https://cepi.net/the-covax-marketplace/.
REFERENCES Adlung, R. 2010. “Trade in Healthcare and Health Insurance Services: WTO/GATS as a Supporting Actor(?)” Intereconomics 45 (4): 227–38. Adlung R., and A. Carzaniga. 2001. “Health Services under the General Agreement on Trade Services.” Bulletin of the World Health Organization 79 (4): 352–64. Agarwal, R., and T. Reed. Forthcoming. “Financing Vaccine Equity: Funding for Day Zero of the Next Pandemic.” Oxford Review of Economic Policy 38 (4). Anderson, R. D., W. E. Kovacic, A. C. Müller, and N. Sporysheva. 2018. “Competition Policy, Trade and the Global Economy: Existing WTO Elements, Commitments in Regional Trade Agreements, Current Challenges and Issues for Reflection.” Staff Working Paper ERSD-2018-12, World Trade Organization, Geneva. Anderson, R. D., A. C. Müller, and P. Pelletier. 2017. “Regional Trade Agreements and Procurement Rules: Facilitators or Hindrances?” In The Internationalization of Government Procurement Regulation, edited by A. Georgopoulos, B. Hoekman, and P. C. Mavroidis, 56–85. Oxford: Oxford University Press. ASEAN (Association of Southeast Asian Nations). 2020a. “AEM Signing of the MOUonthe Implementation of Non-Tariff Measures on Essential Goods under the Hanoi POA in Response to theCOVID-19Pandemic.” News release, November 24, ASEAN Secretariat, Jakarta. ASEAN (Association of Southeast Asian Nations). 2020b. “Hanoi Plan of Action on Strengthening ASEAN Economic Cooperation and Supply Chain Connectivity in Response to the COVID-19 Pandemic.” Plan implementing the April 14 “Declaration of the Special ASEAN Summit on the Coronavirus Disease 2019 (COVID-19).” Adopted June 4 at the ASEAN Economic Ministers Meeting, Jakarta. Baiker, L., E. Bertola, and M. Jelitto. 2021. “Services Domestic Regulation – Locking in Good Regulatory Practices: Analyzing the Prevalence of Services Domestic Regulation Disciplines and Their Potential Linkages with Economic Performance.” Staff Working Paper ERSD-2021-4, World Trade Organization, Geneva. Ball, D., S. Roth, and J. Parry. 2016. “Better Regulation of Medicines Means Stronger Regional Health Security: Strengthening and Convergence of National Regulatory Agencies Has Benefits beyond Country Borders.” ADB Briefs No. 54, Asian Development Bank, Manila.
153
